Reports Q2 revenue $3.15B, consensus $2.99B. “Our focus on delivering high quality care, operational excellence, and investment in best practices across prioritized markets and services continues to underpin strong overall business performance,” said Jon Rousseau, Chairman, President, and CEO. “We are committed to delivering coordinated services and excellent care to complex patient populations in our Pharmacy and Provider businesses, which provide significant value to the healthcare system. 2025 has thus far been a very productive year for BrightSpring, as we continue to execute our strategy and deliver results for all stakeholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BTSG Upcoming Earnings Report: What to Expect?
- Wells says CMS proposed rates worse than expected, final rate likely to improve
- Home health stocks under pressure following proposed rate cuts
- BrightSpring Health initiated with a Buy at TD Cowen
- BrightSpring Health Services Executive Resignation Announced